BRITTANY BAIRD: Open Payments
NPI 1467008045 · HARTFORD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 29 payments from 11 companies in 2025. Trend: 2023 $171 · 2024 $207 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| PFIZER INC. | 3 | $46 |
| Corcept Therapeutics | 2 | $40 |
| Novo Nordisk Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Amgen Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: VRAYLAR, UBRELVY, VOQUEZNA, QULIPTA, Korlym, REXULTI, Auvelity, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
